836. Deputy Naoise Ó Muirí asked the Minister for Health her plans to expand the medical cannabis access programme to include chronic pain conditions, including endometriosis; and if she will make a statement on the matter. [68856/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Naoise Ó Muirí under the heading Medicinal Products.
13 questions match, newest first.
1174. Deputy Naoise Ó Muirí asked the Minister for Health if the HSE intends to add amivantamab, which has been approved by the European Medicines Agency, to the list of reimbursable medicines (details supplied); and if she will make a statement on the matter [64521/26]
833. Deputy Naoise Ó Muirí asked the Minister for Health the status of negotiations regarding belzutifan; whether she will expedite the assessment and approval process; and if she will make a statement on the matter. [51584/26]
834. Deputy Naoise Ó Muirí asked the Minister for Health the review she intends to take of Ireland's system for approving access and funding for new drugs and medical treatments; and if she will make a statement on the matter. [51585/26]
959. Deputy Naoise Ó Muirí asked the Minister for Health the frequency with which the HSE PCRS will make a pharmacy liable for the difference between the reference price and reimbursement price of ‘Do Not Substitute’ drugs; the number of claim investigations by the PCRS in 2026; and if she will make a statement on the matter. [45561/26]
2351. Deputy Naoise Ó Muirí asked the Minister for Health the position regarding the availability of the omnipod 5 automated insulin delivery system in Ireland; the status of its approval and reimbursement process; and the timeframe for its expected roll out, in view of its availability in other European countries and the growing demand among Irish diabetes patients for access to advanced insulin delivery technologie…
3179. Deputy Naoise Ó Muirí asked the Minister for Health if her Department has considered reimbursement pathways for GLP-1 therapies in obesity where clinically indicated; and if she will make a statement on the matter. [26338/26]
1032. Deputy Naoise Ó Muirí asked the Minister for Health if she will intervene to ensure that the HSE prioritises the conclusion of reimbursement negotiations for skyclarys, given that it is currently the only available treatment for Friedreich’s ataxia and is identified as addressing an unmet need under the National Rare Disease Strategy 2025–2030; and if she will make a statement on the matter. [22393/26]
254. Deputy Naoise Ó Muirí asked the Minister for Health the progress of licensing the drug luthera, which is required for the treatment of grade 4 neuroendocrine cancer; the expected timeline for approval; and if she will make a statement on the matter. [68274/25]
277. Deputy Naoise Ó Muirí asked the Minister for Health if her attention has been drawn to the proposal that high protein oral nutritional supplements are administered under a managed access programme, the effect this may have on patient well-being and recovery; and if she will make a statement on the matter. [40014/25]
2105. Deputy Naoise Ó Muirí asked the Minister for Health if she will consider introducing legislation (details supplied); and if she will make a statement on the matter. [19274/25]
253. Deputy Naoise Ó Muirí asked the Minister for Health the reason the long-term illness scheme is limited to mental health conditions for persons under 16 years-of-age; whether she has plans to extend this beyond 16 years-of-age; and if she will make a statement on the matter. [3908/25]
254. Deputy Naoise Ó Muirí asked the Minister for Health the reason a medication (details supplied) is excluded from the drugs payment scheme, as it is a necessary medication for people diagnosed with bipolar disorder to treat depressive episodes; whether its inclusion in the scheme will be considered; and if she will make a statement on the matter. [3909/25]